Laboratório Búrigo is a leading player in the Health Care industry, specializing in comprehensive clinical analysis services. Their offering includes advanced bacterioscopy, gene sequencing, and specialized antibody testing. Established in 1981, the company has a wealth of experience and expertise in their field. Their extensive range of tests, such as baf2, bacterioscopy-fresh, bag-bacterioscopy-gram, brcsm, brca1 and brca2 gene sequencing, mlpa, brucg, brucellosis-igg antibodies, bruha, brucellosis-agglutination, meec, butanone, b2mui, beta-2 microglobulin-isolated urine, hla29, birdshot, i6-blatella germanica, and mx1-mold, sets them apart in the market.
There is no investment information
No recent news or press coverage available for Laboratório Búrigo.